Advertising

Editorial
Volume 55, Issue 6, June 2026

When less is more

Justin Coleman   
doi: 10.31128/AJGP-02-26-8027   |    Download article
Cite this article    BIBTEX    REFER    RIS

ArticleImage

Guest editorial: Experts in uncertainty – Strengthening our core skills

First, a confession. I have always been a ‘less is more’ type of general practitioner (GP). I find my people clustering at the outer edges of conference trade floors (hypocritically ordering extra coffee shots) swapping stories of how we tamed an overly enthusiastic registrar or underwhelmed our avant-garde peers on social media.

My career span has seen snowballing diagnostic capability, proliferating treatment options and instantaneous health information. Concepts such as hand-pumping a sphygmomanometer and counting someone’s chromosomes made way for wearable continuous monitoring and whole-genome sequencing with artificial intelligence (AI) suggestions.

Yet early on, I recognised that the drive to do more is not always synonymous with better care. The article by Guppy et al suggests my patients have been all the safer for my hesitancy.1 Ordering tests that do not – or at least should not – meaningfully alter management risks inadvertently taking patients down obscure (and expensive) rabbit holes. General practice is tortuous enough already.

The implication is not to retreat from diagnostic excellence, but to recalibrate when and why we test, and carefully select which patients will benefit from additional medication. A ‘less is more’ lens helps counter the truism that we health practitioners consistently overestimate the benefits of our interventions and underestimate their harms.2

If over-treatment is the problem child of modern medicine, then its parents are overtesting and overdiagnosis – the correct identification of abnormalities that would not cause harm if left untreated.1 This ‘over’ family thrives on the availability of more investigations of higher sensitivity, ever-widening disease definitions and the rise of set-and-forget medication lists that pay too little heed to the perils of polypharmacy.

‘Too much medicine’ is sometimes encouraged by patients, the media, subspecialist narratives and, of course, the medication and device industries. It is by no means peculiar to primary care, but GPs are exceptionally placed to help protect the community from it.

Its harms are real – not merely academic – and include direct harm to patients from unnecessary interventions, plus the cascade effect of tests and treatments begetting more of the same. The myriad opportunity costs suffered downstream might even stretch to include a GP staying back late to battle their overflowing inbox.

Central to the practice of ‘less’ is the skilful management of uncertainty. Doust et al reminds us that we do not require certainty to deliver safe, effective care; we need a nuanced appreciation of risk, experience in contextualising findings, and confidence in our clinical judgement.3 We are not called to be nihilistic – merely prudent.

Even where a diagnosis eludes us, we can be certain instead that we have followed a robust process (history, targeted examination, selective testing) to ensure the patient can safely make headway.

Empathetic communication and shared decision making are powerful safety nets that allow us to practice restraint without alienating the recipient. The relationship gives us permission to prioritise care that matters and avoid interventions that do not.

In the hands of skilled practitioners, restraint can itself be a substantive expression of care.

Competing interests: None.
AI declaration: The author confirms that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript.
This event attracts CPD points and can be self recorded

Did you know you can now log your CPD with a click of a button?

Create Quick log
References
  1. Guppy M, Tracy M, Buchbinder R. Overdiagnosis and overtesting. Aust J Gen Pract 2026;55(6):329– 31. doi: 10.31128/AJGP-11-25-7893. Search PubMed
  2. Hoffmann TC, Del Mar C. Clinicians’ expectations of the benefits and harms of treatments, screening, and tests: A systematic review. JAMA Intern Med 2017;177(3):407–19. doi: 10.1001/jamainternmed.2016.8254. Search PubMed
  3. Doust J, MacIsaac MB, Tam CWM, Knight A, King D. General practitioners do not need to be certain; they need to be safe. Aust J Gen Pract 2026;55(6):334–38. doi: 10.31128/AJGP-10-25-7854. Search PubMed

Communication skillsConsultation skillsEvidence-based medicine

Download article